Time New York: Mon 23 Apr 05:30 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Looking for Value? Why It Might Be Time to Try Nucor (NUE)

Zacks

Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?

Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Nucor Corporation NUE.

Nucor in Focus

NUE may be an interesting play thanks to its forward PE of 11, its P/S ratio of 1, and its decent dividend yield of 2.5%. These factors suggest that Nucor is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that NUE has decent revenue metrics to back up its earnings.

Nucor Corporation PE Ratio (TTM)


Nucor Corporation PE Ratio (TTM) | Nucor Corporation Quote


But before you think that Nucor is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 11.5% in the past 30 days, thanks to four upward revisions in the past one month compared to none lower.

This estimate strength is actually enough to push NUE to a Zacks Rank #1 (Strong Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank stocks here.

So really, Nucor is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.